Friday, March 08, 2013 12:29:55 PM
Some hedge funds decided to unload. Maybe they lost elsewhere and needed cash to cover other positions?
The only thing that makes sense although it seems silly when they could have sold slower in the .80's and .90's.
They have tanked a perfectly good play.
I've decided to use the low price as an opportunity to load up for approval. Frankly this is all an approval bet now.
I doubt we will see any significant run up with most shares (86%) in institutional hands.
The only thing that makes sense although it seems silly when they could have sold slower in the .80's and .90's.
They have tanked a perfectly good play.
I've decided to use the low price as an opportunity to load up for approval. Frankly this is all an approval bet now.
I doubt we will see any significant run up with most shares (86%) in institutional hands.
Recent HRTX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/13/2026 01:05:39 PM
- Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline • IH Market News • 05/11/2026 03:03:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 12:00:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 12:00:16 PM
- Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance • GlobeNewswire Inc. • 05/11/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 05:01:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 04:49:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 04:35:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 03:56:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 03:30:39 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 06:09:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 06:09:05 PM
- Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026 • GlobeNewswire Inc. • 04/27/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 03:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 01:41:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 01:13:37 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 09:13:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 11:06:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/06/2026 12:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:00:26 PM
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 07:40:59 PM
- Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026 • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
